Cardiac pacing and lead devices management: 25 years of research at EP Europace journal

Pascal Defaye; Mauro Biffi; Mikhael El-Chami; Serge Boveda; Michael Glikson; Jonathan Piccini; Marco Vitolo

doi:10.1093/europace/euad202

Cardiac pacing and lead devices management: 25 years of research at EP Europace journal

Europace. 2023 Aug 25;25(8):euad202. doi: 10.1093/europace/euad202.

Authors

Pascal Defaye¹, Mauro Biffi², Mikhael El-Chami³, Serge Boveda⁴, Michael Glikson⁵, Jonathan Piccini⁶, Marco Vitolo^{7

8}

Affiliations

¹ Cardiology Department, University Hospital and Grenoble Alpes University, CS 10217, Grenoble Cedex 9, Grenoble 38043, France.
² Cardiology Unit, Cardiac Thoracic and Vascular Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
³ Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.
⁴ Clinique Pasteur, Heart Rhythm Department, Toulouse, France.
⁵ Cardiology Department, Jesselson Integrated Heart Center Shaare Zedek Medical Center and Hebrew University Faculty of Medicine, Jerusalem, Israel.
⁶ Duke University, Duke Clinical Research Institute, Durham, NC, USA.
⁷ Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico Di Modena, Modena, Italy.
⁸ Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Abstract

Aims: Cardiac pacing represents a key element in the field of electrophysiology and the treatment of conduction diseases. Since the first issue published in 1999, EP Europace has significantly contributed to the development and dissemination of the research in this area.

Methods: In the last 25 years, there has been a continuous improvement of technologies and a great expansion of clinical indications making the field of cardiac pacing a fertile ground for research still today. Pacemaker technology has rapidly evolved, from the first external devices with limited longevity, passing through conventional transvenous pacemakers to leadless devices. Constant innovations in pacemaker size, longevity, pacing mode, algorithms, and remote monitoring highlight that the fascinating and exciting journey of cardiac pacing is not over yet.

Conclusion: The aim of the present review is to provide the current 'state of the art' on cardiac pacing highlighting the most important contributions from the Journal in the field.

Keywords: CIED; Cardiac pacing; Leadless pacing; Pacemaker; State of the art.

Publication types

Review

MeSH terms

Arrhythmias, Cardiac / diagnosis
Arrhythmias, Cardiac / therapy
Cardiac Conduction System Disease / therapy
Cardiac Pacing, Artificial*
Equipment Design
Humans
Pacemaker, Artificial*